Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
GoPro
GPRO
$126M
| $1.16M | ﹤0.01% |
243,100
-74,700
| -24% | -$283K |
|
2602
ICF International
ICFI
$1.72B
| $1.16M | ﹤0.01% |
17,852
+1,670
| +10% | +$109K |
|
2603
Moelis & Co
MC
$4.94B
| $1.15M | ﹤0.01% |
36,988
-28,591
| -44% | -$897K |
|
2604
AAR Corp
AIR
$5.76B
| $1.15M | ﹤0.01% |
55,754
+11,539
| +26% | +$223K |
|
2605
Brinker International
EAT
$9.66B
| $1.15M | ﹤0.01% |
47,951
-12,595
| -21% | -$270K |
|
2606
Workiva
WK
$3.54B
| $1.15M | ﹤0.01% |
21,464
+383
| +2% | +$15.7K |
|
|
CNST
2607
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.15M | ﹤0.01% |
38,176
+11,494
| +43% | +$414K |
|
2608
Capitol Federal Financial
CFFN
$1.1B
| $1.15M | ﹤0.01% |
104,194
+29,559
| +40% | +$339K |
|
2609
CALL
Take-Two Interactive
TTWO
$46.1B
| $1.14M | ﹤0.01% |
8,200
-8,500
| -51% | -$1.11M |
|
2610
CALL
Axalta
AXTA
$8.17B
| $1.14M | ﹤0.01% |
50,700
-23,100
| -31% | -$473K |
|
2611
Vishay Intertechnology
VSH
$5.43B
| $1.14M | ﹤0.01% |
74,891
-6,504
| -8% | -$101K |
|
2612
Matsons
MATX
$6.18B
| $1.14M | ﹤0.01% |
39,189
+3,723
| +10% | +$107K |
|
|
KAMN
2613
DELISTED
Kaman Corp
KAMN
| $1.14M | ﹤0.01% |
27,394
+2,233
| +9% | +$86.5K |
|
2614
Atlantic Union Bankshares
AUB
$5.97B
| $1.14M | ﹤0.01% |
49,122
+16,794
| +52% | +$378K |
|
|
MFA
2615
MFA Financial
MFA
$933M
| $1.14M | ﹤0.01% |
114,231
-22,823
| -17% | -$177K |
|
2616
Adaptive Biotechnologies
ADPT
$3.97B
| $1.14M | ﹤0.01% |
23,469
+21,540
| +1,117% | +$785K |
|
2617
Frontline
FRO
$8.85B
| $1.14M | ﹤0.01% |
162,692
+13,924
| +9% | +$118K |
|
2618
Axos Financial
AX
$5.68B
| $1.13M | ﹤0.01% |
51,187
+3,770
| +8% | +$76.7K |
|
2619
Leggett & Platt
LEG
$1.31B
| $1.13M | ﹤0.01% |
32,163
-59,374
| -65% | -$1.84M |
|
2620
NMI Holdings
NMIH
$3.36B
| $1.13M | ﹤0.01% |
70,279
+5,425
| +8% | +$77.2K |
|
|
CHCT
2621
Community Healthcare Trust
CHCT
$454M
| $1.13M | ﹤0.01% |
27,561
+11,141
| +68% | +$417K |
|
2622
Element Solutions
ESI
$9.23B
| $1.13M | ﹤0.01% |
103,782
-19,934
| -16% | -$200K |
|
2623
AMERISAFE
AMSF
$540M
| $1.13M | ﹤0.01% |
18,388
+1,347
| +8% | +$83.8K |
|
2624
CALL
Applied Materials
AMAT
$428B
| $1.12M | ﹤0.01% |
18,600
-460,700
| -96% | -$24.9M |
|
|
PRNB
2625
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $1.12M | ﹤0.01% |
18,808
-3,647
| -16% | -$225K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.